期刊文献+

系统性红斑狼疮患者体液免疫和ENA酶谱变化及意义 被引量:3

Changes and value of humoral immune and ENA in the patients with SLE
下载PDF
导出
摘要 目的 探讨体液免疫和可提取性核抗原 (ENA)酶谱在系统性红斑狼疮 (SL E)稳定期和活动期中的变化及意义。方法 应用散射速率比浊法检测 5 2例 SL E患者 (下称实验组 )以及 2 4例正常对照者 (对照组 )的Ig G、Ig A、Ig M、C3、C4 等水平 ,应用免疫印记技术检测 ENA酶谱。结果 实验组血清 Ig G、Ig A水平明显高于对照组 ,其中活动期 (实验 B组 )血清 Ig G、Ig A、Ig M高于稳定期患者 (实验 A组 )。实验组血清 C3、C4 水平明显低于对照组 ,且实验 B组 C3水平明显低于实验 A组 ,差异有显著性 (P<0 .0 1)。 4 5 .4 % SL E患者抗 SSA、抗 SSB同时阳性 ,抗 ds DNA阳性率为 32 .7%。抗 r RNP和抗 Sm抗体在实验 A、B组的阳性率有显著差异 (P<0 .0 1,<0 .0 5 ) ,其他抗体均无明显差异。结论  SL E患者行体液免疫指标及 ENA酶谱测定可提示其疾病进展情况。 Objective To investigate the changes of humoral immune and extractable nuclear antigens(ENA) in stable and activity systemic lupus erythem atosus(SLE).Methods The level of IgG,IgA,IgM,C 3,C 4 in 23 stable and 29 activity SLE patients and 24 normal controls were determined by scatter velocity turbidimetry.Anti-extractable nuclear antigens were tested using immunobloting.Results The level of IgG,IgA in SLE were higher than the control group ,the level of IgG,IgA,IgM in activity SLE were higher than that in stable SLE and control group,the level of IgG in stable SLE were higher than control group,all of them have significant difference (P<0.01,<0.05).The level of C 3,C 4 in SLE comparing with the control group were significant decreased (P<0.05),there were significant difference between the activity SLE and stable SLE(P<0.01).Both anti-SSA and anti-SSB were positive in 45.4% patients ,anti-dsDNA had 32.7% positive.There were no difference except for anti-rRNP,anti-Sm between stable SLE and activity SLE.Conclusions The progression of SLE may be showed by testing humoral immune and anti-extractable nuclear antigen.
出处 《山东医药》 CAS 北大核心 2004年第28期6-7,共2页 Shandong Medical Journal
关键词 患者 ENA SLE 体液免疫 对照组 系统性红斑狼疮 实验 水平 期中 结论 Systemic lupus erythematosus Humoral immune Extractable nuclear antigen
  • 相关文献

参考文献9

  • 1Dorner T,Putterman C.B cells,BAFF/zTNF4,TACI,and systemic lupus erythematosus.Arthritis Res,2001,3(4):197~199.
  • 2Ruiz-Irastorza G,Khamashta MA,Castellino G.Systemic lupus erthemqtosus.The Lancet,2001,357:1027~1032.
  • 3Uyttenbroeck W,Cooreman W,Scharpe S,et al.The presence of antibodies against extractable nuclear antigens in serum:a comparison of immunoblotting.Ann Clin Biochem,1993,30:83~88.
  • 4汤爱国,罗学宏,李宝花.SLE患者ENA多肽抗体和IFANA的检测及其临床意义[J].中国现代医学杂志,2000,10(8):63-64. 被引量:7
  • 5邓安梅 仲人前 孔宪涛.SLE中临床免疫指标监测的意义[J].中华皮肤科杂志,1998,31:320-322.
  • 6Alarcon SD,Rniz AA,Liorente L.Broken dog ma:pantration of autoantibody into living cells.Immunl Today,1996,17:163~165.
  • 7徐胜前,刘文涛,徐建华,孙桂华.系统性红斑狼疮患者选择性血清IgM降低[J].中华风湿病学杂志,2000,4(1):31-32. 被引量:9
  • 8Saiki O,Saeki Y,Tanaka T,et al.Development of selective IgM deficiency in systemic lupus erythematosus patients with disease of long duration.Arthritis Rheum,1987,30:1289~1292.
  • 9Sivri A,Hascelik Z.IgM deficiency systemic lupus erythematosus patients.Arthritis Rheum,1995,38:1713~1715.

二级参考文献8

共引文献16

同被引文献10

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部